© 2019 IPHARMA

  • Facebook Social Icon
  • LinkedIn Social Icon
  • YouTube Social  Icon
  • Instagram Social Icon

Cases and

webinars

IPHARMA continue to hold a series of webinars in order to provide information to the vast media audience on various aspects of clinical trials conduct.

The results of clinical trial of  the first domestic DPP-4 inhibitor Gosogliptin

10.12.2015

At the annual conference "Achievements and Prospects of Clinical Endocrinology" the results of clinical trial of  the first domestic DPP-4 inhibitor Gosogliptin has been presented.

Webinar "Development of a clinical trial design"

04.12.2015

The most resource-intensive part of a new drug development is the clinical trial management and conduct. The protocol defines all aspects of the trial and, in the end, the fate of the drug.

Webinar "Clinical trials history. The clinical trial participants and the effective distribution of responsibilities"
27.11.2015

 

When a regular customer walks into a pharmacy and buys medicinal drugs, he can’t even think of a great piece of work that stands behind a new drug development. There are thousands of people, many years of research, huge investments. And all of this in order to make a new drug as safe and effective as possible.

Report "The effective clinical trial design"

24.11.2015

 

The report of IPHARMA Chief Operating Officer Natalia Vostokova report at the Adam Smith Forums "Medical Department in Russia" and "Clinical Trials in Russia".

Report "Pharmacovigilance in local clinical trials"

26.11.2015

The report of IPHARMA Medical Director

Julia Trachtenberg at the Adam Smith Forums "Medical Department in Russia" and "Clinical Trials in Russia".

The efficacy and safety of new HIV reverse transcriptase inhibitor (VM1500, Elpivirin) as part of antiretroviral therapy

30.10.2015

 

IPHARMA article "The efficacy and safety of a new national non-nucleoside inhibitor of HIV reverse transcriptase (VM1500, Elpivirin) as part of antiretroviral therapy " In the journal "Epidemiology and Infectious Diseases" №5 / 2015.